Year

2019

Status

Active

Team

 

Field

cardio-metabolic

Location

Naarden (NL)

Fund

BGV II

NewAmsterdam Pharma

NewAmsterdam Pharma acquired Dezima Pharma and is now a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.